These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23639710)

  • 1. Mechanisms of aspirin desensitization.
    Burnett T; Katial R; Alam R
    Immunol Allergy Clin North Am; 2013 May; 33(2):223-36. PubMed ID: 23639710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Benefit with Aspirin Therapy in Aspirin-Exacerbated Respiratory Disease.
    Hill J; Burnett T; Katial R
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):735-747. PubMed ID: 27712767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation by aspirin of nuclear phospho-signal transducer and activator of transcription 6 expression: Possible role in therapeutic benefit associated with aspirin desensitization.
    Steinke JW; Culp JA; Kropf E; Borish L
    J Allergy Clin Immunol; 2009 Oct; 124(4):724-30.e4. PubMed ID: 19767084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin exacerbated respiratory disease: Current topics and trends.
    Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
    Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eicosanoids, aspirin-intolerance and the upper airways--current standards and recent improvements of the desensitization therapy.
    Pfaar O; Klimek L
    J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():5-13. PubMed ID: 17244950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.
    Steinke JW; Payne SC; Borish L
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):719-734. PubMed ID: 27712766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsteroidal anti-inflammatory-induced inhibition of signal transducer and activator of transcription 6 (STAT-6) phosphorylation in aspirin-exacerbated respiratory disease.
    Katial RK; Martucci M; Burnett T; Faino A; Finkas L; Liu S; Alam R
    J Allergy Clin Immunol; 2016 Aug; 138(2):579-85. PubMed ID: 26915678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukotriene receptors and aspirin sensitivity.
    Arm JP; Austen KF
    N Engl J Med; 2002 Nov; 347(19):1524-6. PubMed ID: 12421897
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis.
    Schapowal AG; Simon HU; Schmitz-Schumann M
    Acta Otorhinolaryngol Belg; 1995; 49(3):235-50. PubMed ID: 7484142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin sensitivity and desensitization for asthma and sinusitis.
    Stevenson DD
    Curr Allergy Asthma Rep; 2009 Mar; 9(2):155-63. PubMed ID: 19210906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease.
    Sehanobish E; Asad M; Barbi M; Porcelli SA; Jerschow E
    Front Immunol; 2021; 12():695815. PubMed ID: 34305932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of misoprostol on patients with aspirin-exacerbated respiratory disease undergoing aspirin challenge and desensitization.
    Walters KM; Simon RA; Woessner KM; Wineinger NE; White AA
    Ann Allergy Asthma Immunol; 2017 Jul; 119(1):71-76. PubMed ID: 28668243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper.
    Macy E; Bernstein JA; Castells MC; Gawchik SM; Lee TH; Settipane RA; Simon RA; Wald J; Woessner KM;
    Ann Allergy Asthma Immunol; 2007 Feb; 98(2):172-4. PubMed ID: 17304886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid Mediators in Aspirin-Exacerbated Respiratory Disease.
    Parker AR; Ayars AG; Altman MC; Henderson WR
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):749-763. PubMed ID: 27712768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis.
    Sousa AR; Parikh A; Scadding G; Corrigan CJ; Lee TH
    N Engl J Med; 2002 Nov; 347(19):1493-9. PubMed ID: 12421891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity to nonsteroidal anti-inflammatory drugs.
    Namazy JA; Simon RA
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):542-50; quiz 550, 605. PubMed ID: 12487218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparable safety of 2 aspirin desensitization protocols for aspirin exacerbated respiratory disease.
    Pelletier T; Roizen G; Ren Z; Hudes G; Rosenstreich D; Jerschow E
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1319-1321. PubMed ID: 30144584
    [No Abstract]   [Full Text] [Related]  

  • 18. Cysteinyl leukotriene receptor expression in aspirin-sensitive nasal polyposis patients.
    Ozen Z; Mumbuc S; Sari I; Baglam T; Karatas E; Kanlikama M
    ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):176-80. PubMed ID: 17264534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Trials of Aspirin Treatment After Desensitization in Aspirin-Exacerbated Respiratory Disease.
    Kowalski ML; Wardzyńska A; Makowska JS
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):705-717. PubMed ID: 27712765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin intolerance: does desensitization alter the course of the disease?
    Klimek L; Pfaar O
    Immunol Allergy Clin North Am; 2009 Nov; 29(4):669-75. PubMed ID: 19879442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.